Compare ELTK & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTK | ECOR |
|---|---|---|
| Founded | 1970 | 2005 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.3M | 49.1M |
| IPO Year | 1998 | 2018 |
| Metric | ELTK | ECOR |
|---|---|---|
| Price | $8.46 | $6.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $18.00 |
| AVG Volume (30 Days) | 3.7K | ★ 79.8K |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.32% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | $16.18 | $33.60 |
| Revenue Next Year | N/A | $30.40 |
| P/E Ratio | $48.71 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $7.73 | $4.16 |
| 52 Week High | $12.19 | $8.55 |
| Indicator | ELTK | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 53.64 |
| Support Level | $8.38 | $4.65 |
| Resistance Level | $9.34 | $7.57 |
| Average True Range (ATR) | 0.38 | 0.61 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 68.98 | 63.21 |
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.